ESCs/iPSCs

Researchers demonstrate how CRISPR/Cas9-mediated exon skipping, or myoediting, may rescue dystrophin function in a majority of Duchenne muscular dystrophy patients

A new study identifies a long non-coding RNA as an important barrier impeding the reprogramming of cells derived from old patients

A new study suggests that DNA methylation analysis of select gene promoters can identify the optimal pluripotent stem cell for bone repair strategies

For the first time, researchers describe the formation of entirely hPSC-derived 3D muscle tissues that survive, vascularize, and maintain function following transplantation

Using an efficient and synchronous reprogramming system, researchers describe the dynamic alterations to genome topology, chromatin states, and gene expression

New research from the University of North Carolina establishes a link between rapid origin licensing and the maintenance of stem cell pluripotency

Comparing the reprogramming of somatic cells of different sources helps researchers to delineate universal and cell-specific pieces of the reprogramming process

Researchers describe how a new “universal” strategy for CRISPR-Cas9-mediated gene correction in patient derived stem cells may represent a promising therapeutic option

Researchers describe how modulating glycan-mediated growth factor association and signaling can maintain mESCs in a pluripotent state

Researchers describe a robust and simple means to assess quality control in cultures of human embryonic stem cell cultures: intact cell mass spectrometry fingerprinting